These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 7835800)

  • 21. Risk of ovarian cancer in BRCA1 and BRCA2 mutation-negative hereditary breast cancer families.
    Kauff ND; Mitra N; Robson ME; Hurley KE; Chuai S; Goldfrank D; Wadsworth E; Lee J; Cigler T; Borgen PI; Norton L; Barakat RR; Offit K
    J Natl Cancer Inst; 2005 Sep; 97(18):1382-4. PubMed ID: 16174860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ovarian intraepithelial neoplasia and ovarian cancer.
    Gershenson DM; Tortolero-Luna G; Malpica A; Baker VV; Whittaker L; Johnson E; Follen Mitchell M
    Obstet Gynecol Clin North Am; 1996 Jun; 23(2):475-543. PubMed ID: 8784888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of anovulation factors on pre- and postmenopausal ovarian cancer risk: revisiting the incessant ovulation hypothesis.
    Tung KH; Wilkens LR; Wu AH; McDuffie K; Nomura AM; Kolonel LN; Terada KY; Goodman MT
    Am J Epidemiol; 2005 Feb; 161(4):321-9. PubMed ID: 15692075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined oral contraceptive use and epithelial ovarian cancer risk: time-related effects.
    Lurie G; Wilkens LR; Thompson PJ; McDuffie KE; Carney ME; Terada KY; Goodman MT
    Epidemiology; 2008 Mar; 19(2):237-43. PubMed ID: 18223481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The myth about contraceptives and breast cancer.
    Ibekwe J
    Dly Times; 1993 Mar; ():7. PubMed ID: 12179509
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.
    Uyei A; Peterson SK; Erlichman J; Broglio K; Yekell S; Schmeler K; Lu K; Meric-Bernstam F; Amos C; Strong L; Arun B
    Cancer; 2006 Dec; 107(12):2745-51. PubMed ID: 17109443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BRCA1 and BRCA2 germ-line mutations and oral contraceptives: to use or not to use.
    Grenader T; Peretz T; Lifchitz M; Shavit L
    Breast; 2005 Aug; 14(4):264-8. PubMed ID: 16085232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
    Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT
    Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advances in the management of epithelial ovarian cancer.
    Memarzadeh S; Berek JS
    J Reprod Med; 2001 Jul; 46(7):621-9; discussion 629-30. PubMed ID: 11499181
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hormone replacement therapy and cancer.
    Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of selected lifestyle factors on breast and ovarian cancer risk in BRCA1 mutation carriers from Poland.
    Gronwald J; Byrski T; Huzarski T; Cybulski C; Sun P; Tulman A; Narod SA; Lubinski J
    Breast Cancer Res Treat; 2006 Jan; 95(2):105-9. PubMed ID: 16261399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral contraceptive use and risk of breast cancer among women with a family history of breast cancer: a prospective cohort study.
    Silvera SA; Miller AB; Rohan TE
    Cancer Causes Control; 2005 Nov; 16(9):1059-63. PubMed ID: 16184471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiology of ovarian cancer.
    Permuth-Wey J; Sellers TA
    Methods Mol Biol; 2009; 472():413-37. PubMed ID: 19107446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Breast cancer risk factors and second primary malignancies among women with breast cancer.
    Trentham-Dietz A; Newcomb PA; Nichols HB; Hampton JM
    Breast Cancer Res Treat; 2007 Oct; 105(2):195-207. PubMed ID: 17186360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ovarian cancer.
    Westhoff C
    Annu Rev Public Health; 1996; 17():85-96. PubMed ID: 8724217
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors of ovarian cancer of epithelial origin: a case control study.
    Koch M; Jenkins H; Gaedke H
    Cancer Detect Prev; 1988; 13(2):131-6. PubMed ID: 3242822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ovarian cancer after hysterectomy.
    McGowan L
    Obstet Gynecol; 1987 Mar; 69(3 Pt 1):386-9. PubMed ID: 3822286
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemiology and prevention of breast cancer.
    Kelsey JL; Bernstein L
    Annu Rev Public Health; 1996; 17():47-67. PubMed ID: 8724215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidemiology and etiology of ovarian cancer: a review.
    Heintz AP; Hacker NF; Lagasse LD
    Obstet Gynecol; 1985 Jul; 66(1):127-35. PubMed ID: 3892386
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Role of mass screening in detection of ovarian tumors].
    Nikolaeva DV
    Vopr Onkol; 1977; 23(3):68-74. PubMed ID: 143125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.